For pharmaceutical companies navigating the complex journey from clinical trial success to market entry, the final phase—commercialization—often represents the most…
Read More
Pharma commercial vendor selection still runs on word of mouth and a Harvard MBA student aims to change that with Rx Almanac.
For pharmaceutical companies navigating the high-stakes transition from clinical development to commercial launch, the landscape of service providers remains remarkably…
Read More
Pharma commercial vendor selection still runs on word of mouth. A Harvard MBA student aims to change that with Rx Almanac.
For pharmaceutical companies navigating the complex transition from clinical success to commercial launch, the process of selecting service providers—ranging from…
Read More
Varda Space Industries Secures $251m in Series D Funding to Pioneer Commercial In-Space Pharmaceutical Manufacturing
Varda Space Industries has successfully closed a massive $251m Series D financing round, bringing its cumulative venture backing to $598m…
Read More
Pharma commercial vendor selection still runs on word of mouth: A Harvard MBA student aims to change that with Rx Almanac
For pharmaceutical companies navigating the complex journey from clinical trial success to market launch, the final hurdle is often the…
Read More
Pharma commercial vendor selection still runs on word of mouth. A Harvard MBA student aims to change that with Rx Almanac.
The pharmaceutical industry, a sector defined by rigorous clinical validation and data-driven R&D, paradoxically relies on archaic, informal methods when…
Read More
Quantum Spin Polarization Breakthrough Could Slash Tritium Needs and Revolutionize Commercial Fusion Energy
A novel fuel optimization strategy developed by researchers at the U.S. Department of Energy’s Princeton Plasma Physics Laboratory (PPPL) could…
Read MorePharma commercial vendor selection still runs on word of mouth: A Harvard MBA student aims to change that with Rx Almanac.
For pharmaceutical companies navigating the complex transition from clinical research to commercial launch, the selection of service providers—ranging from distribution…
Read More
Navigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial Success
The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…
Read More
Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…
Read More
